VRTX · News · 20260824N
Acquisition / Partnership / Divestiture
VERTEX PHARMACEUTICALS INC / MA · 2026-08-24 · Importance 71 · Surprise 60 · No source text
Vertex Pharmaceuticals is progressing with its planned acquisition of Crinetics Pharmaceuticals. The reported transaction value is approximately $10 billion, exceeding the materiality threshold. Crinetics was reported to have approximately $9 billion of market capitalization after its shares reached an all-time high of $84.80.
Key facts
- Vertex Pharmaceuticals reported revenue growth of 12.50%. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +12.5% | Vertex Pharmaceuticals reported revenue growth of 12.50%. |